Intranuclear huntingtin increases the expression of caspase-1 and induces apoptosis.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Human Molecular Genetics

• Publication date

  2000-11-22

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/HMG/9.19.2859PMID 11092762
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Glycogen synthase kinase-3beta facilitates staurosporine- and heat shock-induced apoptosis. Protection by lithium.

  2000cited by this paper
• Mitochondrial dysfunction and free radical damage in the Huntington R6/2 transgenic mouse

  2000cited by this paper
• Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model.

  2000influential reference
• Decreased expression of striatal signaling genes in a mouse model of Huntington's disease.

  2000cited by this paper
• Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease

  2000influential reference
• Glycogen Synthase Kinase-3β Facilitates Staurosporine- and Heat Shock-induced Apoptosis

  2000cited by this paper
• Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice.

  2000cited by this paper
• Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease.

  2000cited by this paper
• Amino-terminal fragments of mutant huntingtin show selective accumulation in striatal neurons and synaptic toxicity

  2000cited by this paper
• The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription.

  2000cited by this paper
• Nuclear targeting of mutant Huntingtin increases toxicity.

  1999cited by this paper
• Nuclear and Neuropil Aggregates in Huntington’s Disease: Relationship to Neuropathology

  1999cited by this paper
• Cellular Defects and Altered Gene Expression in PC12 Cells Stably Expressing Mutant Huntingtin

  1999cited by this paper
• Mitochondrial disease in mouse results in increased oxidative stress.

  1999influential reference
• Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease

  1999influential reference
• Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization

  1999cited by this paper
• Bioenergetics in Huntington's Disease

  1999cited by this paper
• Caspase-8 is required for cell death induced by expanded polyglutamine repeats.

  1999cited by this paper
• Sequential Activation of Caspase-1 and Caspase-3-like Proteases During Apoptosis in Myelodysplastic Syndromes

  1999cited by this paper
• Recent advances on the pathogenesis of Huntington's disease.

  1999cited by this paper
• Manganese Superoxide Dismutase Mediates the Early Release of Mitochondrial Cytochrome C and Subsequent DNA Fragmentation after Permanent Focal Cerebral Ischemia in Mice

  1999cited by this paper
• Ordering the Cytochrome c–initiated Caspase Cascade: Hierarchical Activation of Caspases-2, -3, -6, -7, -8, and -10 in a Caspase-9–dependent Manner

  1999cited by this paper
• Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: correlation between the density of inclusions and IT15 CAG triplet repeat length.

  1998cited by this paper
• Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene.

  1998cited by this paper
• A cellular model that recapitulates major pathogenic steps of Huntington's disease.

  1998cited by this paper
• The Permeability Transition Pore Complex: A Target for Apoptosis Regulation by Caspases and Bcl-2–related Proteins

  1998cited by this paper
• Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions.

  1998cited by this paper
• Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice.

  1998cited by this paper
• Reduced Ischemic Brain Injury in Interleukin-1β Converting Enzyme—Deficient Mice

  1998cited by this paper
• Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis.

  1998cited by this paper
• Increased Vulnerability to 3‐Nitropropionic Acid in an Animal Model of Huntington's Disease

  1998cited by this paper
• Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA

  1998cited by this paper
• Expression of a Dominant Negative Mutant of Interleukin-1β Converting Enzyme in Transgenic Mice Prevents Neuronal Cell Death Induced by Trophic Factor Withdrawal and Ischemic Brain Injury

  1997cited by this paper
• FLICE is activated by association with the CD95 death‐inducing signaling complex (DISC)

  1997cited by this paper
• The Central Executioner of Apoptosis: Multiple Connections between Protease Activation and Mitochondria in Fas/APO-1/CD95- and Ceramide-induced Apoptosis

  1997cited by this paper
• Inhibition of ICE slows ALS in mice

  1997influential reference
• Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade.

  1997cited by this paper
• Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation.

  1997cited by this paper
• Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.

  1997cited by this paper
• Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage.

  1997cited by this paper
• Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis

  1996cited by this paper
• Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c.

  1996cited by this paper
• Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase.

  1995cited by this paper
• Mch3, a novel human apoptotic cysteine protease highly related to CPP32.

  1995cited by this paper
• Yama/CPP32β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase

  1995cited by this paper
• CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme.

  1994cited by this paper
• Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases.

  1994cited by this paper
• A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.

  1993cited by this paper

• Analytical Review on Normal Brain Aging, Alzheimer’s Disease, and Stage 4S Neuroblastoma: Novel Insights Into Neuroprotection, Neurodegeneration, and Spontaneous Regression

  2025cites this paper
• Functions of Astrocytes under Normal Conditions and after a Brain Disease

  2023cites this paper
• Role of Astrocytes in Central Nervous System, Disease Implications and New Physiological Implications in Memory and Learning

  2021cites this paper
• Huntington’s disease: Pathophysiology and therapeutic intervention

  2021cites this paper
• Hepatitis C Virus-Related Central and Peripheral Nervous System Disorders

  2021cites this paper
• Apoptosis as a warrior or an opponent

  2021cites this paper
• The Interaction of Aging and Cellular Stress Contributes to Pathogenesis in Mouse and Human Huntington Disease Neurons

  2020cites this paper
• The interaction of aging and oxidative stress contributes to pathogenesis in mouse and human Huntington disease neurons

  2019cites this paper
• The interaction between RE1-silencing transcription factor (REST) and heat shock protein 90 as new therapeutic target against Huntington’s disease

  2019cites this paper
• Heterozygous huntingtin promotes cadmium neurotoxicity and neurodegeneration in striatal cells via altered metal transport and protein kinase C delta dependent oxidative stress and apoptosis signaling mechanisms

  2019cites this paper
• A Review on Huntington ’ s Disease

  2018cites this paper
• Interrogation of Rab8 as a therapeutic target for Huntington’s disease in Drosophila melanogaster

  2017cites this paper
• More alive than dead: non-apoptotic roles for caspases in neuronal development, plasticity and disease

  2017cites this paper
• CNS inflammation and neurodegeneration.

  2017cites this paper
• Folding Landscape of Mutant Huntingtin Exon1: Diffusible Multimers, Oligomers and Fibrils, and No Detectable Monomer

  2016cites this paper
• Cardiac Fas-Dependent and Mitochondria-Dependent Apoptotic Pathways in a Transgenic Mouse Model of Huntington’s Disease

  2016cites this paper
• Impact of caspase-6 modulation on Huntington disease phenotypes in the YAC128 mouse model

  2016cites this paper
• Recombinant Adeno Associated Viral (AAV) vector type 9 delivery of Ex1-Q138-mutant huntingtin in the rat striatum as a short-time model for in vivo studies in drug discovery.

  2016cites this paper
• Animal Models of Spinocerebellar Ataxia Type 1

  2015cites this paper
• Antidepressants for neuroprotection in Huntington's disease: A review.

  2015cites this paper
• FACULTAD DE FARMACIA UNIVERSIDAD COMPLUTENSE

  2015cites this paper
• Rosiglitazone activation of PPARγ-dependent signaling is neuroprotective in mutant huntingtin expressing cells.

  2015cites this paper
• Region-specific interneuronal degeneration in the human cerebral cortex in Huntington’s disease correlates with symptomatology

  2015cites this paper
• DNA Repair Deficiency in Huntington's Disease Fibroblasts and Induced Pluripotent Stem Cells

  2015cites this paper
• Re-establishing ataxin-2 downregulates translation of mutant ataxin-3 and alleviates Machado-Joseph disease.

  2015cites this paper
• From Pathways to Targets: Understanding the Mechanisms behind Polyglutamine Disease

  2014cites this paper
• Bioprospecting in the Berkeley Pit: The Use of Signal Transduction Enzyme Inhibition Assays to Isolate Bioactive Secondary Metabolites from the Extremophilic Fungi of an Acid Mine Waste Lake

  2013cites this paper
• Huntingtin and mitosis

  2012cites this paper
• Triple Repeat Diseases of the Nervous Systems

  2012cites this paper
• Promoters Are Differentially Sensitive to N-Terminal Mutant Huntingtin-Mediated Transcriptional Repression

  2012cites this paper
• CANNABINOIDS REGULATE TYPE 1 CANNABINOID RECEPTOR EXPRESSION IN CELL CULTURE MODELS OF HUNTINGTON'S DISEASE

  2012cites this paper
• INVESTIGATING THE MECHANISM OF PROMOTER-SPECIFIC N-TERMINAL MUTANT HUNTINGTIN-MEDIATED TRANSCRIPTIONAL DYSREGULATION

  2012cites this paper
• Matter of life and death: the pharmacological approaches targeting apoptosis in brain diseases.

  2011cites this paper
• The ubiquitin proteasome system in Huntington disease : impairment of the proteolytic machinery aggravates huntingtin aggregation and toxicity

  2011cites this paper
• The paradigm of Huntington’s disease: Therapeutic opportunities in neurodegeneration

  2011cites this paper
• Tilapia (Oreochromis mossambicus) antimicrobial peptide, hepcidin 1-5, shows antitumor activity in cancer cells.

  2011cites this paper
• Physiological and Pathological Role of Apoptosis

  2010cites this paper
• Expression of Huntington's disease protein results in apoptotic neurons in the brains of cloned transgenic pigs.

  2010cites this paper
• Slow Degradation and Aggregation In Vitro of Mutant GABAA Receptor γ2(Q351X) Subunits Associated with Epilepsy

  2010cites this paper
• SlowDegradationandAggregationInVitroofMutant GABA A Receptor2(Q351X)SubunitsAssociatedwith Epilepsy

  2010cites this paper
• BimEL as a possible molecular link between proteasome dysfunction and cell death induced by mutant huntingtin

  2010cites this paper
• Neurochemical Aspects of Neurodegenerative Diseases

  2010cites this paper
• Influence of Interferon-γ on Salmonella Typhi Induced Macrophage Apoptosis

  2010cites this paper
• The Multiple Roles of the Innate Immune System in the Regulation of Apoptosis and Inflammation in the Brain

  2009cites this paper
• The molecular pathogenesis of Huntington’s disease

  2009cites this paper
• Characterization of the interaction between a stable G-quartet forming oligonucleotide and huntingtin with an expanded poly-glutamine region

  2009cites this paper
• Regulation of apoptosis at the point of cytochrome c in disease models

  2009cites this paper
• Increased Apoptosis of CD 20 + IgA + B Cells is the Basis for IgA Deficiency : The Molecular Mechanism for Correction In Vitro by IL-10 and CD 40 L

  2009cites this paper
• The pathogenic mechanisms of polyglutamine diseases and current therapeutic strategies

  2009cites this paper
• Apoptosis in Neurodegeneration: Programmed Cell Death and its Role in Alzheimer’s and Huntington’s Diseases

  2008cites this paper
• A critical evaluation of adenosine A2A receptors as potentially "druggable" targets in Huntington's disease.

  2008cites this paper
• Proteomic and oxidative stress analysis in human brain samples of Huntington disease.

  2008cites this paper
• AAV-mediated expression of Bcl-xL or XIAP fails to induce neuronal resistance against quinolinic acid-induced striatal lesioning.

  2008cites this paper
• Defective signal transduction in B lymphocytes lacking presenilin proteins

  2008cites this paper
• Inhibition of neurite outgrowth and promotion of cell death by cytoplasmic soluble mutant huntingtin stably transfected in mouse neuroblastoma cells.

  2008cites this paper
• Analysis of transgenic mouse models of Huntington's disease

  2008cites this paper
• Transcriptional Dysregulation and Computational Models for Cell Death Caused by Protein Aggregation

  2008cites this paper
• Modelling and treating Huntington’s disease: Generation of high-capacity adenovirus vectors to express normal and mutant huntingtin and to block huntingtin expression by short hairpin interference RNA

  2008cites this paper
• Comparative Genomics and Molecular Dynamics of DNA Repeats in Eukaryotes

  2008cites this paper
• Ubiquitin-conjugating enzyme E2-25K increases aggregate formation and cell death in polyglutamine diseases.

  2007cites this paper
• RECOMBINANT APOPTIN MULTIMERS KILL TUMOR CELLS BUT ARE NONTOXIC AND EPITOPE-SHIELDED IN A NORMAL-CELL-SPECIFIC FASHION C H A PT E R 2

  2007cites this paper
• Neuronal Apoptosis in Neurodegeneration

  2007cites this paper
• Interactions of HIPPI, a molecular partner of Huntingtin interacting protein HIP1, with the specific motif present at the putative promoter sequence of the caspase‐1, caspase‐8 and caspase‐10 genes

  2007cites this paper
• Cytochrome C and caspase-9 expression in Huntington’s disease

  2007cites this paper
• Cell suicide and caspases.

  2007cites this paper
• Effects of chronic ethanol drinking on the blood brain barrier and ensuing neuronal toxicity in alcohol-preferring rats subjected to intraperitoneal LPS injection.

  2007cites this paper
• Effects of Bacterial Toxins on Endothelial Tight Junction In Vitro: A Mechanism-Based Investigation

  2007influential citation
• Increased Caspase-2, Calpain Activations and Decreased Mitochondrial Complex II Activity in Cells Expressing Exogenous Huntingtin Exon 1 Containing CAG Repeat in the Pathogenic Range

  2007cites this paper
• Interaction of HIPPI with putative promoter sequence of caspase-1 in vitro and in vivo.

  2007cites this paper
• Chapter 3 – Genetic and Environmental Factors in Neurodegenerative Diseases

  2007cites this paper
• Selective degeneration in YAC mouse models of Huntington disease.

  2007cites this paper
• AAV-vector mediated gene delivery for Huntington's Disease : an investigative therapeutic study.

  2007cites this paper
• Role of heat shock proteins during polyglutamine neurodegeneration

  2007cites this paper
• Inflammatory caspases: targets for novel therapies.

  2007cites this paper
• Mutant huntingtin alters MAPK signaling pathways in PC12 and striatal cells: ERK1/2 protects against mutant huntingtin-associated toxicity.

  2006influential citation
• The effects of leptin, gip and clenbuterol on bone marrow gene expression

  2006cites this paper
• Cytotoxicity of a mutant huntingtin fragment in yeast involves early alterations in mitochondrial OXPHOS complexes II and III.

  2006cites this paper
• Expression of an expanded polyglutamine domain in yeast causes death with apoptotic markers.

  2006cites this paper
• ETUDE DE L'AMPLIFICATION DE LA NEURODEGENERESCENCE EXCITOTOXIQUE PAR UNE DYSFONCTION MITOCHONDRIALE : IMPLICATIONS POUR LA MALADIE DE HUNTINGTON

  2006cites this paper
• Huntingtin is localized in the nucleus during preimplanatation embryo development in mice

  2006influential citation
• Context-dependent Dysregulation of Transcription by Mutant Huntingtin*

  2006cites this paper
• Multiple pathways contribute to the pathogenesis of Huntington disease

  2006cites this paper
• Aging and neurodegeneration. Molecular mechanisms of neuronal loss in Huntington's disease.

  2006cites this paper
• Increased Apoptosis of CD20+ IgA+ B Cells is the Basis for IgA Deficiency: The Molecular Mechanism for Correction In Vitro by IL-10 and CD40L

  2006cites this paper
• Cell-Based Therapy for Huntington’s Disease

  2006cites this paper
• Wild‐type huntingtin protects neurons from excitotoxicity

  2006cites this paper
• Inactivation of Drosophila Apaf-1 related killer suppresses formation of polyglutamine aggregates and blocks polyglutamine pathogenesis.

  2005cites this paper
• Molecular study of cell culture models of Parkinson's disease and Huntington's disease.

  2005cites this paper
• Prevention of cytosolic IAPs degradation: a potential pharmacological target in Huntington's Disease.

  2005cites this paper
• Characterization and treatment of mouse models of Huntington disease

  2005cites this paper
• Dysregulation of Receptor Interacting Protein-2 and Caspase Recruitment Domain Only Protein Mediates Aberrant Caspase-1 Activation in Huntington's Disease

  2005influential citation
• Selective degeneration and nuclear localization of mutant huntingtin in the YAC128 mouse model of Huntington disease.

  2005cites this paper
• Bioprospecting in the Berkeley pit: Bio active metabolites from acid mine waste extremophiles

  2005cites this paper
• CHAPTER K3 – Animal Models of Spinocerebellar Ataxia Type 1 (SCA1)

  2005cites this paper
• DDI032 357..372

  2005cites this paper
• Apoptose als möglicher Pathomechanismus der Nervenzelldegeneration beim M. Huntington

  2005cites this paper
• Expression of Expanded Polyglutamine Disease Proteins in Drosophila (Drosophila Polyglutamine Disease Models)

  2005cites this paper
• Induction of hypoxia inducible factor‐1 attenuates metabolic insults induced by 3‐nitropropionic acid in rat C6 glioma cells

  2005cites this paper
• Apoptin: Specific killer of tumor cells?

  2005cites this paper
• Genetic and environmental factors in the pathogenesis of Huntington’s disease

  2004cites this paper